Additionally, we analyzed the mechanism whereby CBD overcomes oxaliplatin resistance in CRC cells and report, for the first time, that CBD downregulates NOS3 activity, resulting in mitochondrial dysfunction and finally, leading to autophagy. Here, NOS3 is linked to colorectal carcinoma.